A synthesis of (R)-(-)-phenylpiperidin-1-yl-acetic acid 2 starting from (R)-(-)-α-phenylglycine 1 is described. Additionally, an enantiopure synthesis of bietamiverine 6 and dipiproverine 7 using as starting material 2 is reported.
Introduction
Chirality is a major concern in the modern pharmaceutical industry. This interest can be attributed largely to a heightened awareness that enantiomers of a racemic drug may have different pharmacological activities, as well as different pharmacokinetic and pharmacodynamic effects. Thus, one isomer may produce the desired therapeutic activities while the other may be inactive or, in worst cases, produce unwanted effects. 1 However, bietamiverine and dipiproverine have been only synthesized as racemic mixtures by transformation of phenylacetic and these are used as antispasmodic and anticholinergic respectively. [2] [3] [4] (Scheme 1). 
Results and Discussion
In this work, we described an enantiopure synthesis of (R)-(-)-phenylpiperidin-1-yl-acetic acid 2 starting from (R)-(-)-α-phenylglycine 1. Additionally, we reported an enantiopure synthesis of bietamiverine 6 and dipiproverine 7 using as starting material compound 2. (Scheme 2).
Scheme 2
Racemization studies of enantiopure phenylglycine and its derivatives have been of interest to divers specialists. Analytical chemists find it a challenge to measure the rate of racemization using small quantities while synthetic peptide chemists take precautions to avoid the process. 5 In this context, we investigated firstly the conditions to convert the (R)-(-)-α-phenylglycine 1 into compound 2 and evaluated its enantiomeric purity. We found that if a suspension of 1 in ethanol in presence of sodium bicarbonate is added 1,5-dibromopentane and stirred during 8 h gave 2 in 95% yield. In this process, we can establish that between 40°C and 50°C was possible to avoid the racemization of 1 to furnish 2 in its enantiopure form. (Scheme 3). 
Scheme 5
Finally, to confirm the optical purity of 6 and 7, these compounds were converted into 8 with LiAlH 4 , in 90% yield. All spectral properties of this compound were in complete agreement with those reported in our previous publication. (Scheme 6). Scheme 6
Conclusions
We have described an efficient enantiopure synthesis of (R)-(-)-phenylpiperidin-1-yl-acetic acid 2 starting from (R)-(-)-α-phenylglycine 1. According to our knowledge, this is the first report that describes the conditions to prepare the enantiopure compounds 2, 6 and 7.
Experimental Section General Procedures.
.1 H NMR spectra of CDCl 3 solutions were recorded with a Varian Unity instrument at 300 and 400 MHz (internal tetramethylsilane as reference). IR spectra were obtained with a Nicolet FT-IR Magna 750 spectrometer. Chromatography was carried out using Al 2 O 3 . Mass spectra were recorded with a JEOL JEM-AX505HA instrument at a voltage of 70 eV. Optical rotations were determined at room temperature with a Perkin-Elmer 341 polarimeter, using a 1dm cell with a total volume of 1mL and are referenced to the D-line of sodium. was vigorously stirred for 4 h, then poured into NH 4 Cl solution (5 mL), extracted with dichloromethane (3x10 mL) and the extract was washed with water (2x10 mL), dried over sodium sulfate and evaporated in vacuo. Compound 6 and 7 were obtained as colorless oil in 90% yield respectively after purification by column chromatography on Al 2 O 3 (dichloromethane/n-hexane). 
